Helena Teede
Tracked across 1 events · 145 articles · First seen May 12, 2026 · Last active Jun 03, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Polycystic Ovary Syndrome (PCOS), a hormonal condition affecting one in eight women globally, has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change, announced in The Lancet after 14 years of global collaboration led…
Impact: Helena Teede, Director of Monash Centre for Health Research and Implementation, led the global initiative to rename Polyendocrine metabolic ovarian syndrome, advocating for a more accurate and comprehensive understanding of the condition.
May 12, 2026 · 145 articles
90
Helena Teede chaired steering group Polyendocrine metabolic ovarian syndromePCOS Renamed Polyendocrine...
90
Helena Teede led teamPCOS Renamed Polyendocrine...
70
Helena Teede led researchPCOS Renamed Polyendocrine...
60
Helena Teede described conditionPCOS Renamed Polyendocrine...
NEWSDESK
Track Helena Teede live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard